Pittsburgh, PA, United States of America

Christopher M Hobson

This inventor holds 2 USPTO granted patents. Top assignee: University of Pittsburgh. Active years: 2018-2021.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2021

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Christopher M Hobson: Innovator in Tissue Decellularization

Introduction

Christopher M Hobson is a notable inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of tissue decellularization, holding 2 patents that focus on innovative methods for preparing extracellular matrix (ECM) from mammalian tissues. His work is essential for advancements in regenerative medicine and tissue engineering.

Latest Patents

Hobson's latest patents include a "Method and apparatus for decellularization of tissue" and a "Method for decellularization of tissue." The first patent provides methods for decellularizing mammalian tissue and creating ECM preparations, along with systems and apparatus to facilitate these methods. The second patent outlines techniques for decellularization using cyclical pressure changes, further enhancing the efficiency of ECM preparation.

Career Highlights

Christopher M Hobson is affiliated with the University of Pittsburgh, where he continues to advance research in tissue decellularization. His innovative approaches have garnered attention in the scientific community, contributing to the development of new methodologies in the field.

Collaborations

Hobson has collaborated with notable colleagues, including Thomas W Gilbert and Ethan N Ungchusri. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.

Conclusion

Christopher M Hobson is a prominent figure in the field of tissue decellularization, with valuable patents that contribute to medical advancements. His work at the University of Pittsburgh and collaborations with fellow researchers underscore his commitment to innovation in regenerative medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…